No human trial has compared a CoQ10 and PQQ stack with CoQ10 on its own. Two preclinical studies did compare them, and neither found the pair better. Here is what the research supports, and how to get the most from CoQ10.
Two 2025 meta-analyses found CoQ10 improved sperm concentration, motility and morphology, with pregnancy rates improving mainly past three months of use. The dose, the duration and the limits all matter more than the headline.
NMN has been well tolerated in human trials at doses up to 1,250 mg daily, with no serious adverse events reported. But the longest trial ran just 12 weeks, and as of a July 2026 notice, the FSSAI lists NMN as an unapproved supplement ingredient in India.
Milk thistle has one of the widest gaps between what supplement labels promise and what controlled trials found. Pooled NAFLD data looks encouraging, the best-controlled 48-week trial found nothing, and an analysis of 26 commercial supplements may explain why.
NMN raises NAD+ in human blood. That much is settled. Two meta-analyses published in 2025 looked at overlapping trials and reached opposite conclusions about gait speed, and FSSAI has called NMN an unapproved ingredient for supplements in India.
Why yoga and cardio alone are not enough for healthy ageing in Indians, what strength training actually does to metabolism and insulin sensitivity, and how to build a fitness routine that compounds over decades.
Why memory slips, focus fades, and motivation flattens after 40, and the specific biological mechanisms behind each. Everything The Oak Age has written on brain health and cognitive function.
Peptide protocols are spreading fast through fitness and longevity circles. What the human evidence actually covers, the sales funnel and supply chain sitting behind them, and the question almost nobody asks before they start.